| HOME >> BIOLOGY >> TECHNOLOGY |
Innovative treatments for WNV 218
Western equine encephalitis 218
Sporadic virus epidemics 218
Coronavirus/severe acute respiratory syndrome 218
Therapeutic approaches to SARS 219
MAbs for SARS 219
siRNA treatment of SARS 220
Zoonotic viral infections 220
Vaccines for zoonotic viral diseases 220
Virus bioterrorism and biowarfare 221
Small pox as a biological weapon 221
Status of small pox vaccination 221
Strategies against virus bioterrorism and biowarfare 222
Increasing resistance by stimulating innate immune mechanisms 222
Nanoviricides for combating viral bioterrorism 223
Concluding remarks 223
12. Markets for Antivirals 225
Introduction 225
Markets according to disease 225
Influenza market 225
HIV/AIDS market 226
Hepatitis B and C markets 227
Markets according to products and approaches 227
Market values of monoclonal antibodies for viral diseases 227
Market values of vaccines for viral diseases 227
Markets for vaccines against HPV 228
Markets for other antiviral vaccines 228
Markets according to geographical areas 229
Geographical distribution of HIV/A
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |